Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity

Brian E Burke1, Phillip S Mushlin, Barry J Cusack

  • 1Medical Research Service, Department of Veterans Affairs Medical Center, Boise, ID 83702, USA. drq10@iglide.net

Insights

Pediatric patients show increased sensitivity to anthracycline cardiotoxicity. This study found neonatal rabbit hearts resistant to anthracyclines, suggesting different mechanisms of cardiac damage in developing versus adult hearts.

Area of Science:

  • Cardiovascular Pharmacology
  • Pediatric Oncology
  • Molecular Cardiology

Background:

  • Anthracyclines are vital chemotherapy drugs, but their use is limited by cardiotoxicity.
  • Pediatric patients exhibit heightened sensitivity to anthracycline-induced cardiotoxicity, with underlying mechanisms remaining unclear.
  • The sarcoplasmic reticulum (SR) is implicated in adult anthracycline cardiotoxicity, but its role in developing myocardium is unexamined.

Purpose of the Study:

  • To investigate the acute effects of anthracyclines on cardiac contractility in adult and neonatal rabbit models.
  • To compare the impact of anthracyclines on sarcoplasmic reticulum (SR) function in developing versus mature myocardium.
  • To elucidate potential differences in mechanisms of cardiotoxicity between pediatric and adult populations.

Main Methods:

  • Compared acute effects of doxorubicin, daunorubicin, and caffeine on contractile function in adult and neonatal rabbit myocardium.
  • Assessed concentration-dependent inhibition of frequency-dependent contractility, relaxation times, and post-rest potentiation.
  • Evaluated the role of sarcoplasmic reticulum (SR) calcium stores and function.

Main Results:

  • Adult myocardium showed concentration-dependent inhibition of contractile function and impaired SR function with anthracyclines and caffeine.
  • Neonatal myocardium demonstrated resistance to the acute cardiotoxic effects of anthracyclines and caffeine.
  • Contractile dysfunction correlated with differences in SR maturation between adult and neonatal hearts.

Conclusions:

  • Anthracyclines induce acute cardiac lesions in adults via effects on the sarcoplasmic reticulum (SR).
  • Developing myocardium appears resistant to anthracycline-induced SR dysfunction, suggesting alternative mechanisms for cardiotoxicity.
  • Findings highlight potential age-dependent differences in anthracycline cardiotoxicity mechanisms, crucial for pediatric treatment strategies.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...